Clinical Trial Detail

NCT ID NCT02535806
Title Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Mercy Hospital Kansas City
Indications

acute lymphoblastic leukemia

lymphoid leukemia

B-cell acute lymphoblastic leukemia

T-cell lymphoblastic leukemia/lymphoma

Therapies

Vincristine Sulfate

Bortezomib

Pegaspargase

Methotrexate

Cytarabine

Mitoxantrone

Prednisone

Age Groups: adult child

No variant requirements are available.